Amir Enshaei, PhD^1*, Claire Schwab^2*, Lucy Chilton, PhD^1*, Rachel Wade, MSc^3*, Jeremy Hancock, PhD^4*, Christopher Mitchell, MBBS, PhD, FRCP^5*, Sally E Kinsey⁶, Nicholas Goulden, MD, PhD⁷, Ajay J. Vora⁸, Christine Harrison, PhD FRCPath FMedSci¹ and Anthony V. Moorman, PhD¹

¹Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
²Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
³CTSU, Oxford, United Kingdom
⁴Bristol Genetics Laboratory, Southmead Hospital, Bristol, United Kingdom
⁵John Radcliffe Hospital, Oxford, United Kingdom
⁶St. James' Univ. Hospital, Leeds, United Kingdom
⁷Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom
⁸Dept. of Pediatric Hematology, The Children's Hospital, Sheffield, United Kingdom

Jack Bartram, MD^1*, David O'Connor, MD, PhD^1*, Amir Enshaei, PhD^2*, Anthony V Moorman, PhD², Christine Harrison, PhD FRCPath FMedSci², Rachel Wade, MSc^3*, Rachel Clack, MSc^3*, Jeremy Hancock, PhD^4*, Sujith Samarasinghe, MD, PhD^1*, John Moppett, MD, PhD^5*, Ajay J. Vora⁶ and Nicholas Goulden, MD, PhD¹

¹Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom
²Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
³CTSU, University of Oxford, Oxford, United Kingdom
⁴Bristol Genetics Laboratory, Southmead Hospital, Bristol, United Kingdom
⁵Department of Pediatric Haematology, Bristol Royal Hospital for Children, Bristol, England
⁶Dept. of Pediatric Hematology, The Children's Hospital, Sheffield, United Kingdom

Elizabeth Raetz, MD¹, Mignon L. Loh, MD², Meenakshi Devidas, PhD³, Kelly Maloney, MD⁴, Eric C. Larsen, MD^5*, Leonard A. Mattano Jr., MD⁶, Michael J. Borowitz, MD, PhD⁷, Brent L Wood, MD, PhD⁸, Andrew J. Carroll, PhD⁹, Nyla A. Heerema, PhD¹⁰, I-Ming Chen, DVM, MS^11*, Alison M. Friedmann, MD, MSC^12*, Kirk R. Schultz, MD¹³, Mary V. Relling, PharmD¹⁴, Richard C Harvey, PhD¹⁵, Julie Gastier-Foster, PhD^16*, Cheryl L. Willman, MD¹⁷, Naomi J. Winick, MD¹⁸, Stephen P Hunger, MD¹⁹ and William L. Carroll, MD²⁰

¹Department of Pediatrics, Huntsman Cancer Institute and Primary Children's Hospital, University of Utah, Salt Lake City, UT
²Department of Pediatrics, Benioff Children’s Hospital, University of California at San Francisco, San Francisco, CA
³Department of Biostatistics, Colleges of Medicine, Public Health & Health Profession, University of Florida, Gainesville, FL
⁴The Childrens' Hospital Colorado, Aurora, CO
⁵Maine Children's Cancer Program, Scarborough, ME
⁶HARP Pharma Consulting, Mystic, CT
⁷Hematologic Pathology, Johns Hopkins University, Baltimore, MD
⁸Seattle Cancer Care Alliance, Seattle, WA
⁹Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
¹⁰Pathology, The Ohio State University, Columbus, OH
¹¹Department of Pathology, University of New Mexico, Albuquerque, NM
¹²Pediatric Hematology/Oncology, Massachusetts General Hosp., Boston, MA
¹³B.C. Children's Hospital, University of British Columbia, Vancouver, BC, Canada
¹⁴Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
¹⁵Pathology, University of New Mexico Cancer Center, Albuquerque, NM
¹⁶Department of Pathology, Nationwide Children's Hospital, Columbus, OH
¹⁷UNM Cancer Research Facility, University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM
¹⁸University of Texas Southwestern Medical Center, Dallas, TX
¹⁹Department of Pediatrics, Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
²⁰Department of Pediatrics, Perlmutter Cancer Center,, New York University Medical Center, New York, NY

Jonathan Bond, MD PhD^1*, Tony Marchand, MD^2*, Aurore Touzart, MD^1*, Agata Cieslak^1*, Amélie Trinquand, MD^3*, Laurent Sutton, MD^4*, Isabelle Radford-Weiss^5*, Salvatore Spicuglia, PhD^6*, Hervé Dombret, MD⁷, Elizabeth Macintyre, MD, PhD¹, Norbert Ifrah, MD⁸, Jean-François Hamel^8* and Vahid Asnafi, MD PhD^1*

¹Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut national de recherche médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France
²Department of Hematology, University Hospital and INSERM UMR 917, Rennes 1 University, Rennes, France
³Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France
⁴Hematology Department, Argenteuil Hospital, Argenteuil, France
⁵Université Paris 5 Descartes, Department of Cytogenetics, AP-HP, Hôpital Necker-Enfants Malades, Paris, France
⁶Technological Advances for Genomics and Clinics (TAGC), INSERM U1090, Aix-Marseille University UMR-S 1090, Marseille, France
⁷Université Paris Diderot, Institut Universitaire d’Hématologie, EA-3518, AP-HP, University Hospital Saint-Louis, Paris, France
⁸PRES LUNAM, CHU Angers service des Maladies du Sang et INSERM U 892, Angers, France

Rumen Kostadinov, PhD^1*, Robert Scharpf, Ph.D.^2,3* and Patrick Brown, MD¹

¹Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
²Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
³Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD

Jesus Duque-Afonso, MD¹, Michael C. Wei, MD, PhD², Chiou-Hong Lin, PhD^1*, Jue Feng, PhD^1*, Corina Buechele, MD^1*, Stephen Hon-Kit Wong, PhD^1*, Michael C Bassik, PhD^3* and Michael L. Cleary, MD¹

¹Department of Pathology, Stanford University, Stanford, CA
²Department of Pediatrics, Stanford University, Stanford, CA
³Department of Genetics, Stanford University, Stanford, CA